Clinical Trial Detail

NCT ID NCT01853046
Title Pharmacokinetics and Safety of Regorafenib (BAY73-4506) in Cancer Subjects With Severe Renal Impairment
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements no
Sponsors Bayer
Indications

Advanced Solid Tumor

Therapies

Regorafenib

Age Groups: adult senior

No variant requirements are available.